Excessive dietary sodium has long been recognized as a primary catalyst for cardiovascular complications, most notably hypertension. However, an expanding body of medical literature suggests that the physiological toll of a high-salt diet (HSD) extends far beyond the circulatory system, encroaching upon neurological and emotional well-being. Recent findings indicate that chronic high sodium intake can interfere with cognitive processing, memory retention, and emotional regulation. While public health campaigns continue to emphasize sodium reduction, mitigating the existing cellular and molecular damage caused by high-salt diets remains a critical clinical challenge.
Addressing this medical hurdle, a team of researchers in Japan has identified a promising therapeutic candidate: LPC70, a specialized compound derived from soybeans. Building upon previous preclinical observations that demonstrated the compound’s capacity to counter salt-induced hypertension and cognitive decline in murine models, a new study provides a granular look at the underlying biological mechanisms. Published in Volume 197 of Neurochemistry International on July 1, 2026—following an initial online release on May 14, 2026—the research illuminates how LPC70 modulates critical chemical signaling pathways within both the kidneys and the brain.
The investigation was spearheaded by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in collaboration with Dr. Kazuhiro Kagotani. Prof. Mouri and Dr. Kubota are affiliated with the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals & Devices at Fujita Health University Graduate School of Medical Science, alongside the International Center for Brain Science (ICBS) at Fujita Health University. Dr. Kagotani brings industry and academic insight through his affiliations with Tsuji Oil Mills Co., Ltd., and the Tsuji Health and Beauty Science Laboratory at Mie University.
Understanding Prostaglandin Signaling and the High-Salt Dilemma
To comprehend the therapeutic action of LPC70, researchers had to examine prostaglandins (PGs)—signaling molecules synthesized from arachidonic acid (AA). Functioning similarly to localized hormones, prostaglandins modulate essential physiological processes across diverse organ systems. Within the cardiovascular matrix, these molecules regulate blood pressure by balancing vasodilation and vasoconstriction.
Their operational framework within the central nervous system, however, is considerably more intricate. Depending on the specific cellular receptors they engage, prostaglandins can either trigger neuroprotective mechanisms or instigate neuroinflammatory pathways that impair cognition, memory, and affective responses.
LPC70 represents a distinct formulation of soy lysolecithin, characterized by lysophosphatidylcholine (LPC) accounting for over 70 percent of its total phospholipid content. Although preceding animal trials confirmed that LPC70 could alleviate salt-associated hypertension and cognitive deficits, the precise molecular pathways—particularly its regulation of prostaglandin signaling—remained poorly defined.
Dr. Kubota, serving as the study’s first author, coordinated the experimental design. His methodology involved tracking blood pressure metrics, evaluating behavioral adaptations, and quantifying prostaglandin-associated molecular activity. His analysis clarified how LPC70 exerts differential effects across target organs implicated in sodium-induced pathology.
"We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," stated Professor Mouri, detailing the trajectory of the study. "Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd., a company that develops naturally derived food ingredients."
Chronology and Experimental Findings in Murine Models
The investigation utilized controlled murine models exposed to a high-salt diet. As anticipated, the subjects developed elevated blood pressure, confirming the standard cardiovascular sequelae of excessive sodium intake. However, behavioral assessments revealed that the clinical manifestations were not limited to the vascular system.
Mice subjected to the high-salt regimen exhibited diminished social interaction and impaired object recognition memory, pointing to targeted deficits in complex cognitive processing. Conversely, general locomotor activity and baseline anxiety-like behaviors remained unchanged, indicating that excess sodium selectively disrupts higher-order social and cognitive functions rather than inducing generalized neurological incapacitation.
Upon supplementing the subjects’ high-salt diets with LPC70, researchers observed a pronounced reversal of these pathologies. Blood pressure metrics trended toward normal values, and the test subjects demonstrated restored performance in social interaction and memory recognition trials.
These phenotypic improvements prompted a deep molecular analysis of the subjects’ renal and cerebral tissues.
Divergent Protective Mechanisms in Kidneys and Brain
The molecular examination revealed tissue-specific responses to both the high-salt diet and the LPC70 intervention. In the renal system, excessive sodium consumption upregulated two critical components of prostaglandin signaling: cyclooxygenase-2 (COX-2) and the PGE2 receptor EP3. Both proteins are recognized contributors to salt-sensitive hypertension.
Administration of LPC70 suppressed these salt-induced elevations, indicating that the soy-derived compound helps normalize renal signaling pathways responsible for systemic blood pressure control.
A markedly different mechanism was observed in the prefrontal cortex, the cerebral region governing executive function, memory, and social behavior. Exposure to excess sodium suppressed the expression of the PGD2 receptor DP1, a receptor instrumental in neuroprotective and anti-inflammatory signaling. LPC70 administration successfully restored DP1 receptor expression without altering DP2, a secondary receptor linked to neurotoxic outcomes.
This receptor-specific modulation highlights a sophisticated mechanism of action. Rather than universally upregulating or suppressing prostaglandin activity, LPC70 selectively prioritizes pathways that foster neuroprotection and suppress inflammation, thereby reconciling the cognitive improvements observed during behavioral testing.
Optimizing Arachidonic Acid Utilization
In addition to receptor-level adjustments, the research team identified an unexpected alteration in arachidonic acid dynamics. Subjects consuming a high-salt diet exhibited suppressed levels of circulating arachidonic acid. Paradoxically, when these subjects received LPC70 supplementation, the downstream metabolites derived from this fatty acid—specifically PGE2 and PGD2—experienced an increase.
This counterintuitive finding implies that LPC70 enhances the metabolic efficiency with which the body utilizes available arachidonic acid under high-salt conditions. Consequently, the compound orchestrates a dual-action defense: suppressing hypertension-promoting pathways in the kidneys while simultaneously restoring neuroprotective signaling networks in the brain.
Implications and Future Directions for Human Health
The identification of LPC70’s targeted efficacy opens new avenues for functional food science and nutritional therapeutics. Given that modern dietary patterns frequently exceed recommended sodium intake thresholds, interventions capable of mitigating the systemic consequences of high-salt consumption hold substantial public health value.
Nevertheless, researchers emphasize a crucial caveat: these findings are currently restricted to preclinical animal models. Translating these outcomes into clinical frameworks will require rigorous human trials to establish safety, bioavailability, and therapeutic efficacy.
"Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," concluded Prof. Mouri.
The successful publication of this study marks a significant step forward in understanding the nutritional modulation of chronic dietary stress. By bridging the gap between molecular biology and dietary science, the research offers a framework for developing targeted interventions against the multi-systemic damage driven by high-salt diets.
Financial support for this study was provided through Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS codes: 20K07931, 22K07606, 22K11891, and 23H02843). Additional backing was supplied by the Fujita Mind-Brain Research & Innovation Center for Drug Generation (Fujita Mind-BRIDGe) under Japan’s Peak Research Universities (J-PEAKS) Program (JPJS00420240019), alongside the Japan Science and Technology Agency FOREST Program (JPMJFR215H). Further operational and financial support was rendered by Tsuji Oil Mills Co., Ltd., the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.
